The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 343:1723-1724 December 7, 2000 Number 23
NextNext

Conquering Hepatitis C, Step by Step

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Zeuzem, S.
-Related Article
 by Heathcote, E. J.
-PubMed Citation
Hepatitis C virus (HCV) infection is the most common chronic blood-borne infection in the United States.1 In most of the estimated 2.7 million people who have the infection it has not been diagnosed, and most of those with a diagnosed infection have not been treated. Because the best current medical therapy is expensive, complex, relatively ineffective, and fraught with side effects, many physicians are understandably reluctant to offer it to their patients. Without a highly effective therapy, the condition of patients with hepatitis C continues to deteriorate until complications of cirrhosis develop. The infection progresses to end-stage liver disease in . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.